Industry News

Boehringer Ingelheim inaugurates the Shanghai "Center of Competence" as a part of the company's EUR 100 million expansion project in China Biotechnology
Boehringer Ingelheim inaugurates the Shanghai "Center of Competence" as a part of the company's EUR 100 million expansion project in China Biotechnology
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA™ Lung Disease
Boehringer Ingelheim inaugurates the Shanghai "Center of Competence" as a part of the company's EUR 100 million expansion project in China Biotechnology
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA™ Lung Disease
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA™ Lung Disease
Midatech and Monosol Rx Announce Filing of Joint Patent Application for Nanoparticle Film Delivery Systems Nanoparticles
Reports on women's health findings from Jordan University of Science and Technology provide new insights Women's Health
Midatech and Monosol Rx Announce Filing of Joint Patent Application for Nanoparticle Film Delivery Systems Nanoparticles
Reports on women's health findings from Jordan University of Science and Technology provide new insights Women's Health
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
In Africa, research shows donated malaria drugs smuggled into private markets
Ascension Orthopedics Receives FDA Approval for TITAN™ Modular Total Shoulder System
Ascension Orthopedics Receives FDA Approval for TITAN™ Modular Total Shoulder System
CEO says Genzyme for sale
Allergan Resolves United States Government Investigation of Past Sales and Marketing Practices Relating to Certain Therapeutic Uses of BOTOX®
Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
Target to launch clinics in Chicago, south Florida
Cincinnati, Detroit selected as final health IT pilot communities under innovative HHS Recovery Act Beacon Program
Risks and Benefits of Long-Term Use of Nicotine Replacement Therapy Products; Public Workshop; Request for Comments
Cincinnati, Detroit selected as final health IT pilot communities under innovative HHS Recovery Act Beacon Program
Cincinnati, Detroit selected as final health IT pilot communities under innovative HHS Recovery Act Beacon Program
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
Pfizer to Acquire FoldRx Pharmaceuticals FoldRx Focused on First-in-Class, Disease-Modifying, Oral Therapeutics to Treat Diseases Caused by Protein MisfoldingLead Product Candidate, Tafamidis, in Registration in the European Union as First-in-Class Oral T